BIOMIMETIC THERAPEUTICS, INC. (BMTI) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 1000 transactions totaling $45.7M, demonstrating a bullish sentiment with $32.7M in net insider flow. The most recent transaction on Mar 1, 2013 involved a transaction of 6,846 shares valued at $0.
No significant insider buying has been recorded for BMTI in the recent period.
No significant insider selling has been recorded for BMTI in the recent period.
Based on recent SEC filings, insider sentiment for BMTI is bullish with an Insider Alignment Score of 86/100 and a net flow of $32.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BIOMIMETIC THERAPEUTICS, INC. (BMTI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading BMTI stock, having executed 1000 transactions in the past 90 days. The most active insider is A/s Novo (Executive), who has made 562 transactions totaling $26.0M.
Get notified when executives and directors at BMTI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 1, 2013 | B. Ehrlich Christopher | Executive | Disposition | 6,846 | $N/A | $0 | |
| Mar 1, 2013 | B. Ehrlich Christopher | Executive | Disposition | 857,692 | $N/A | $0 | |
| Mar 1, 2013 | B. Ehrlich Christopher | Executive | Disposition | 24,538 | $N/A | $0 | |
| Mar 1, 2013 | B. Ehrlich Christopher | Executive | Disposition | 1,250 | $N/A | $0 | |
| Mar 1, 2013 | B. Ehrlich Christopher | Executive | Disposition | 941,177 | $N/A | $0 | |
| Mar 1, 2013 | Eugene Lynch Samuel | Executive | Disposition | 1,392,923 | $N/A | $0 | |
| Mar 1, 2013 | Eugene Lynch Samuel | Executive | Option Exercise | 51,000 | $3.47 | $177.0K | |
| Mar 1, 2013 | Eugene Lynch Samuel | Executive | Option Exercise | 170,000 | $2.08 | $353.6K | |
| Mar 1, 2013 | Eugene Lynch Samuel | Executive | Disposition | 5,550 | $N/A | $0 | |
| Mar 1, 2013 | Eugene Lynch Samuel | Executive | Payment | 77,623 | $9.07 | $704.0K | Large |
| Mar 1, 2013 | E. Bullock Lawrence | Executive | Disposition | 89,151 | $N/A | $0 | |
| Mar 1, 2013 | E. Bullock Lawrence | Executive | Disposition | 21,000 | $N/A | $0 | |
| Mar 1, 2013 | W. Papasan Larry | Executive | Option Exercise | 20,000 | $2.63 | $52.6K | |
| Mar 1, 2013 | W. Papasan Larry | Executive | Disposition | 69,517 | $N/A | $0 | |
| Mar 1, 2013 | W. Papasan Larry | Executive | Option Exercise | 18,736 | $5.80 | $108.7K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 620 | $39.2M | 74.8% |
Sale(S) | 208 | $6.5M | 12.4% |
Exercise(M) | 91 | $4.2M | 8.1% |
Payment(F) | 9 | $2.5M | 4.7% |
Disposition(D) | 22 | $0 | 0.0% |
Gift(G) | 44 | $0 | 0.0% |
Other(J) | 5 | $0 | 0.0% |
Award(A) | 1 | $0 | 0.0% |
Insiders at BIOMIMETIC THERAPEUTICS, INC. are accumulating shares at an accelerated pace. With 18 insiders making 1000 transactions totaling $39.2M in purchases versus $6.5M in sales, the net buying activity of $32.7M signals strong executive confidence. A/s Novo (Executive) leads the buying activity with $26.0M in transactions across all time.